Antiviral Prophylaxis in a Burn Population

Summary

A prospective, randomized trial to calculate incidence of Herpes Simplex Virus in an in-patient burn population and determine efficacy of prophylactic antiviral therapy to prevent viral infection and/or reactivation. Hypothesis is that antiviral prophylaxis will be effective in reducing HSV infection/reactivation.

Timeline

Start

2015-09

Primary completion

2016-04

Completion

2016-04

Drugs

Indications